• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病和心脏损伤对 COVID-19 患者住院死亡率的影响:系统评价和荟萃分析。

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.

机构信息

Department of Cardiology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.

Department of Heart Function, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.

出版信息

Heart. 2020 Aug;106(15):1142-1147. doi: 10.1136/heartjnl-2020-317062. Epub 2020 May 27.

DOI:10.1136/heartjnl-2020-317062
PMID:32461330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7295861/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has produced a significant health burden worldwide, especially in patients with cardiovascular comorbidities. The aim of this systematic review and meta-analysis was to assess the impact of underlying cardiovascular comorbidities and acute cardiac injury on in-hospital mortality risk.

METHODS

PubMed, Embase and Web of Science were searched for publications that reported the relationship of underlying cardiovascular disease (CVD), hypertension and myocardial injury with in-hospital fatal outcomes in patients with COVID-19. The ORs were extracted and pooled. Subgroup and sensitivity analyses were performed to explore the potential sources of heterogeneity.

RESULTS

A total of 10 studies were enrolled in this meta-analysis, including eight studies for CVD, seven for hypertension and eight for acute cardiac injury. The presence of CVD and hypertension was associated with higher odds of in-hospital mortality (unadjusted OR 4.85, 95% CI 3.07 to 7.70; I=29%; unadjusted OR 3.67, 95% CI 2.31 to 5.83; I=57%, respectively). Acute cardiac injury was also associated with a higher unadjusted odds of 21.15 (95% CI 10.19 to 43.94; I=71%).

CONCLUSION

COVID-19 patients with underlying cardiovascular comorbidities, including CVD and hypertension, may face a greater risk of fatal outcomes. Acute cardiac injury may act as a marker of mortality risk. Given the unadjusted results of our meta-analysis, future research are warranted.

摘要

背景

2019 年冠状病毒病(COVID-19)在全球范围内造成了巨大的健康负担,尤其对合并心血管疾病的患者影响更大。本系统评价和荟萃分析的目的是评估潜在心血管合并症和急性心脏损伤对住院死亡率风险的影响。

方法

检索 PubMed、Embase 和 Web of Science 以获取报告 COVID-19 患者潜在心血管疾病(CVD)、高血压和心肌损伤与住院死亡结局之间关系的文献。提取并汇总 OR 值。进行亚组和敏感性分析以探索潜在的异质性来源。

结果

共有 10 项研究纳入本荟萃分析,其中 8 项研究用于 CVD,7 项研究用于高血压,8 项研究用于急性心脏损伤。存在 CVD 和高血压与更高的住院死亡率几率相关(未经调整的 OR 4.85,95%CI 3.07 至 7.70;I²=29%;未经调整的 OR 3.67,95%CI 2.31 至 5.83;I²=57%,分别)。急性心脏损伤也与未经调整的 odds 更高(21.15,95%CI 10.19 至 43.94;I²=71%)相关。

结论

患有潜在心血管合并症(包括 CVD 和高血压)的 COVID-19 患者可能面临更大的致命结局风险。急性心脏损伤可能是死亡率风险的标志物。鉴于本荟萃分析的未经调整结果,需要进一步的研究。

相似文献

1
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.心血管疾病和心脏损伤对 COVID-19 患者住院死亡率的影响:系统评价和荟萃分析。
Heart. 2020 Aug;106(15):1142-1147. doi: 10.1136/heartjnl-2020-317062. Epub 2020 May 27.
2
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
3
Getting to the heart of the matter of COVID-19.直击新冠疫情的核心问题。
Heart. 2020 Aug;106(15):1117-1118. doi: 10.1136/heartjnl-2020-317118. Epub 2020 May 27.
4
Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19.新型冠状病毒肺炎患者心肌损伤生物标志物与心脏并发症及病死率的关系。
Arq Bras Cardiol. 2020 Aug 28;115(2):273-277. doi: 10.36660/abc.20200372.
5
Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.基础合并症对 COVID-19 患者死亡发生的影响:系统评价和荟萃分析。
J Glob Health. 2020 Dec;10(2):020503. doi: 10.7189/jogh.10.020503.
6
Cardiac Troponin as a Predictor of Myocardial Injury and Mortality from COVID-19.心肌肌钙蛋白作为新型冠状病毒肺炎(COVID-19)所致心肌损伤及死亡的预测指标
Arq Bras Cardiol. 2020 Oct;115(4):667-668. doi: 10.36660/abc.20200862.
7
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.预测 COVID-19 不良预后的因素:系统评价和荟萃分析。
Eur J Clin Invest. 2020 Oct;50(10):e13362. doi: 10.1111/eci.13362. Epub 2020 Aug 27.
8
Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.冠状病毒病(COVID-19):一项系统综述和荟萃分析,以评估各种合并症对严重事件的影响。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1017-1025. doi: 10.1016/j.dsx.2020.06.064. Epub 2020 Jul 2.
9
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.合并症与 2019 年冠状病毒病相关的严重或致命结局风险:系统评价和荟萃分析。
Int J Infect Dis. 2020 Oct;99:47-56. doi: 10.1016/j.ijid.2020.07.029. Epub 2020 Jul 25.
10
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究:中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.

引用本文的文献

1
The Conditions of Survival of Patients with a SARS-CoV-2 Infection Burdened by Cardiovascular Pathologies in a Temporary Hospital in Gdańsk in 2021 and 2022.2021年和2022年格但斯克临时医院中感染SARS-CoV-2且伴有心血管疾病的患者的生存状况
J Clin Med. 2025 Apr 18;14(8):2806. doi: 10.3390/jcm14082806.
2
Dominance of dengue virus serotype-2 in Pakistan (2023-2024): Molecular characterization of the envelope gene and exploration of antiviral targets.2023 - 2024年巴基斯坦登革热病毒2型的优势地位:包膜基因的分子特征及抗病毒靶点探索
Virus Res. 2024 Dec;350:199497. doi: 10.1016/j.virusres.2024.199497. Epub 2024 Nov 23.
3
Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease.Gamma COVID-19 变异株对住院心血管疾病孕产妇预后的影响。
Clinics (Sao Paulo). 2024 Aug 8;79:100454. doi: 10.1016/j.clinsp.2024.100454. eCollection 2024.
4
Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses.2019冠状病毒病中的心脏损伤:相关荟萃分析的系统评价
Rev Cardiovasc Med. 2022 Dec 12;23(12):404. doi: 10.31083/j.rcm2312404. eCollection 2022 Dec.
5
The Value of Ischemic Cardiac Biomarkers to Predict Spontaneous Breathing Trial or Extubation Failure: A Systematic Review.缺血性心脏生物标志物预测自主呼吸试验或拔管失败的价值:一项系统评价。
J Clin Med. 2024 May 30;13(11):3242. doi: 10.3390/jcm13113242.
6
Determinants of mortality in hypertensive patients admitted with COVID-19: a single-centre retrospective study at a tertiary hospital in South Africa.南非一家三级医院的 COVID-19 住院高血压患者死亡率的决定因素:一项单中心回顾性研究。
BMC Cardiovasc Disord. 2024 Jun 10;24(1):298. doi: 10.1186/s12872-024-03964-2.
7
Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series.COVID-19患者的急性心肌梗死——文献数据综述与两例病例报告系列
J Clin Med. 2024 May 16;13(10):2936. doi: 10.3390/jcm13102936.
8
Epidemiological Features and Outcomes of COVID-19 in Patients With and Without Cardiovascular Disease.心血管疾病患者与非心血管疾病患者 COVID-19 的流行病学特征和结局。
Arch Iran Med. 2023 Jun 1;26(6):316-321. doi: 10.34172/aim.2023.48.
9
A systematic review and meta-analysis on the effects of ill health and health shocks on labour supply.一项关于健康不良和健康冲击对劳动力供给影响的系统评价和荟萃分析。
Syst Rev. 2024 Feb 3;13(1):52. doi: 10.1186/s13643-024-02454-y.
10
Simultaneous Double-Vessel Coronary Thrombosis with Sudden Cardiac Arrest as the First Manifestation of COVID-19.COVID-19 以心脏骤停为首现症状的同时性双血管冠状动脉血栓形成。
Medicina (Kaunas). 2023 Dec 25;60(1):39. doi: 10.3390/medicina60010039.

本文引用的文献

1
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.新冠病毒感染患者的动脉高血压与死亡风险:系统评价与荟萃分析
J Infect. 2020 Jul;81(1):e84-e86. doi: 10.1016/j.jinf.2020.03.059. Epub 2020 Apr 11.
2
Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China.中国武汉 102 例 2019 年冠状病毒病患者的临床特征和短期预后。
Clin Infect Dis. 2020 Jul 28;71(15):748-755. doi: 10.1093/cid/ciaa243.
3
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响:综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
4
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
5
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响:一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
6
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
7
CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic.《新型冠状病毒肺炎流行期间心血管急危重症患者临床管理专家共识》
Circulation. 2020 May 19;141(20):e810-e816. doi: 10.1161/CIRCULATIONAHA.120.047011. Epub 2020 Mar 27.
8
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究:中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
9
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.一种急性呼吸道感染遭遇了最常见的非传染性流行病——新冠肺炎与心血管疾病。
JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.
10
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.中国武汉 2019 年冠状病毒病死亡和康复病例的临床特征:回顾性研究。
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.